Phase 1a randomized double-blind placebo-controlled single-ascending dose and multiple-ascending dose studies of orally inhaled GB002 in healthy adult subjects

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2020
This article has no abstract
Epistemonikos ID: f68d0d801aff7bafe1e50ed2e27a06db20923a1f
First added on: Feb 11, 2025